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Abstract
Background: A rapid expansion of hand, foot, and mouth disease (HFMD) outbreaks has occurred and caused
deaths in China in recent years, but little is known about the other etiologic agents except enterovirus 71 (EV71)
and coxsackievirus A 16 (CA16). The objective of this study is to determine the genotype compositions of
enterovirus causing HFMD in Shanghai and identify any associations between enterovirus types and clinical
manifestations.
Methods: Stool specimens were collected from patients hospitalized for treatment of HFMD, from May 2010 to
April 2011. Enterovirus was detected by reverse transcription PCR and directly genotyped by sequencing the PCR
products. Phylogenetic analysis was based on the VP1 partial gene.
Results: Of 290 specimens, 277 (95.5%) tested positive for enterovirus. The major genotypes were EV71 (63.8%),
CA10 (9.0%), CA6 (8.3%), CA16 (6.9%), CA12 (2.4%), and CA4 (1.4%). The EV71 strains belonged to the C4a subtype
and CA16 belonged to the B subtype. CA6 was closely related to strains detected in Japan, Taiwan and China, and
CA10, CA12 and CA4 were phylogenetically similar to other strains circulating in China. Mean hospital stays and the
prevalence of complications in patients with EV71 infection were higher than those in patients in CA6, CA10 or
CA16 infection (P < 0.05 for all comparisons). Children with CA12 infection were the youngest, and most likely have
the highest risk of complications when compared to the other non-EV71 infection groups.
Conclusions: This study demonstrated a diversified pathogen compositions attributing to HFMD and clinical
symptoms differing in enterovirus genotypes. It deserves our attention as early identification of enterovirus
genotypes is important for diagnosis and treatment of HFMD patients.
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Background
Hand, foot, and mouth disease (HFMD), first reported
in New Zealand in 1957, is a global and common
infectious disease in young children, particularly in
those less than 5 years old. Vesicular exanthema
develops on the hands, feet, mouth and buttocks.
The disease usually resolves spontaneously, but severe
complications, including death, can occur [1-4].
Large-scale outbreaks have occurred in China and
caused 126 and 353 deaths in the year of 2008 and
2009, respectively (http://www.chinacdc.cn/tjsj/fdcrbbg/
201002/t20100224_25293.htm) [1-7].
Hand, foot, and mouth disease is caused by human
enterovirus, a genus of the Picornavirus family, and is char-
acterized by a single 7.4kb of positive-strand genomic RNA.
The genomes contain only a single long open reading frame
that encodes four structural proteins (VP1 through VP4)
and seven non-structural proteins (2A, 2B, 2C, 3AB, 3C
and RNA-dependent RNA polymerase 3D), which are
responsible for viral replication and protein processing. The
VP1 is the most external and immunodominant picorna-
virus capsid protein and contains the major neutralization
epitopes that has been used for virus serotype identification
and evolutionary studies [8-10].
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Enterovirus genotypes are classified into four species, A,
B, C and D, on the basis of genome organization, sequence
similarity and biological properties [11]. Enterovirus 71
(EV71) and coxsackievirus A16 (CA16) belonging to species
A are the most common causes of HFMDworldwide [1]. Se-
vere EV71-associated clinical syndromes, such as acute flac-
cid paralysis, brainstem encephalitis, rapid fatal pulmonary
edema, and hemorrhage, have been observed in many out-
breaks and is considered an important cause of severe
HFMD [2,3]. CA16 associated HFMD has a milder outcome
and a much lower incidence of severe complications [12].
Though HFMD has become a public issue in China,
little is known about the other etiologic agents except
EV71 and CA16. Sporadic reports demonstrated that
various enterovirus genotypes, such as CA2, CA4, CA5,
CA6, CA8, CA10 and CA12 from species A, CB2 and
CB4 from species B and some echoviruses can cause
HFMD [13-17]. However, studies on the relationship of
these genotypes with clinical symptoms are lacking.
In this study, we aimed to investigate the genotypes of
enterovirus contributing to HFMD and to identify any
associations between enterovirus types and clinical man-
ifestations in Shanghai, China.
Methods
Sample collection
From 1 May 2010 to 30 April 2011, stool specimens were
collected from patients hospitalized for HFMD at children’s
Hospital of Fudan University, Shanghai, China. All the
patients were diagnosed by the Ministry of Health diagnos-
tic criteria (http://www.nhfpc.gov.cn/yzygj/s3593g/201306/
6d935c0f43cd4a1fb46f8f71acf8e245.shtml). The complica-
tions involve diseases in neurologic, respiratory or circula-
tory system that caused by HFMD, such as aseptic
meningitis, encephalitis, acute flaccid paralysis, pulmonary
oedema or cardiorespiratory failure, which were defined in
“A Guide to Clinical Management and Public Health Re-
sponse for Hand, Foot and Mouth Disease (HFMD)”
(http://www.wpro.who.int/publications/docs/
GuidancefortheclinicalmanagementofHFMD.pdf).
Patients’ demographic data, clinical symptoms, and major
complications were collected retrospectively from medical
history. This study was approved by the Ethics Committee
in the Children’s Hospital of Fudan University. Because the
specimens were collected in the normal course of patient
care, no informed consent was required according to the
Ethics Committee.
Human enterovirus testing
From supernatants of 10% (V/V) stool specimens, RNA was
extracted by Trizol (Invitrogen, CA, USA) according to the
manufacturer’s instructions. The RNA was dissolved in 20
μL DEPC (Diethypyrocarbonate) water. cDNA was synthe-
sized using 4 μL of extracted RNA, 100 μmol of random
primers, and 2.5 U of reverse transcriptase (PrimeScript TM
RT kit, Takara, Dalian, China). The reverse transcriptase re-
action was carried out at 37°C for 30 min and 85°C for 5 s.
Human enterovirus was preliminarily detected with
highly conserved 5′UTR primers. The first PCR step was
performed in a reaction volume of 25 μL, including 2 μL
cDNA, 0.5 μmol each of outer primers (EV1F: 5′-
CGGCCCCTGAATGCGGC-3′, EV1R: 5′-CACCGGAT
GGCCAATCCA-3′), 50 μmol dNTP, and 0.75U of ExTaq
DNA polymerase (Takara, Dalian, China). The PCR proto-
col was to use an initial temperature of 94°C for 1 min,
followed by 35 cycles of 94°C for 30 s, 55°C for 30s, 72°C
for 30 s, and 72°C for 7 min. Then 1 μL of DNA from
the first round of PCR was used as the template in the sec-
ond round of PCR with the inner primers (EV2F: 5′-
CCCCTGAATGCGGCTAAT-3′, EV2R: 5′-ATTGTCAC
CATAAGCAGCCA-3′) under the same reaction system
and cycling conditions. The PCR products were subjected
to electrophoresis in a 2% agarose gel to identify positive
samples with a predicted size of 146 bp.
Enterovirus genotyping
For enterovirus genotyping, samples tested positive by
the 5′UTR were amplified by nested PCR using primers
from the VP1 junction region of enterovirus as described
[18]. For the first round of PCR, 2 μL of cDNA was used
in a volume of 25 μL containing 0.5 μmol each of outer
primers, 50 μmol of dNTP, and 0.75U of ExTaq DNA
polymerase in the following cycling conditions: 35 cycles
of 94°C for 30 s, 54°C for 45 s, 72°C for 30 s, and a
final incubation of 72°C for 7 min. A volume of 2 μL of
the product was used for the second round of PCR with
0.5 μmol each of inner primers, 50 μmol of dNTP, and
0.75U of ExTaq DNA polymerase in a volume of 25 μL
undergoing the same PCR conditions as described above.
The final product of the different groups of enterovirus
was visualized by agarose gel electrophoresis. DNA frag-
ments were purified and the nucleotide sequence of each
PCR product was bi-directional sequenced on a 3730
sequencer (Pekin-Elmer Applied Biosystems, Foster City,
CA). The PCR products used for the sequencing were
about 683 bp for the group A, 619 bp for the group B
and 497 bp for the 5′UTR.
Phylogenetic analysis and sequence submission
Sequence analysis of the PCR product of each strain was
analyzed with Seqscanner software (Applied Biosystems,
USA), and genetic identity was determined by com-
paring the sequence with standard strains in Genbank
(US National Center for Biotechnology Information,
NCBI). A multiple-sequence alignment was constructed
using ClustalW and phylogenetic trees were performed
applying the neighbor-joining method with the 1000-
bootstrap re-sampling implemented in the Molecular
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Evolutionary Genetics Analysis, version 5.0 program.
All the VP1 gene sequences were submitted to GenBank
sequence database (NCBI, Betheseda, MD, USA) with
given accession numbers KC834832-KC834854 for CA6,
KC834855-KC834877 for CA10, KC834878-KC834892 for
CA16 and KC834893-KC835055 for EV71. The phylogen-
etic trees have been deposited in TreeBASE (# 14766).
Statistical methods
The means of the continuous variables and the propor-
tions of the categorical variables were compared using
Student’s t test, x2 tests, and Fisher’s exact test, as appro-
priate. All data met the assumptions of the tests used to
analyze them. Alpha was set at 0.05. Data analysis was
performed using SPSS version 17.0 for windows.
Results
Enterovirus genotypes
Of 290 specimen, 277 (95.5%) tested positive for entero-
virus. Except for 8 specimens that could not be typed,
nine different genotypes were identified with different
Figure 1 Phylogenetic analysis with the neighbor-joining method based on the alignment of the 468 nucleotide VP1 gene of 163
Shanghai EV71 strains. The 59 reference strains were obtained from the US National Center for Biotechnology Information’s Genbank.
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detection rates: EV71 (63.8%, 185/290), CA10 (9.0%, 26/
290), CA6 (8.3%, 24/290), CA16 (6.9%, 20/290), CA12
(2.4%, 7/290), CA4 (1.4%, 4/290), CA14 (0.3%, 1/290),
Echo6 (0.3%, 1/290), and HEV-C (0.3%, 1/290). No
mixed infections were found.
Phylogenetic analysis of enterovirus genotypes
The partial VP1 sequence of the 163 EV71 strains from
each of the patients was used for phylogenetic analysis.
The nucleotide homologies in all the EV71 strains
ranged from 90.7% to 100%. The molecular epidemi-
ology of the Shanghai EV71 strains was determined with
a phylogenetic dendrogram, with the reference EV71
strains from Genbank representing all the known sub-
genotypes (A, B0-B5, C1-C5). The dendrogram showed
that all the EV71 strains clustered in the same lineages
as a sub-genotype C4. The sequences in sub-genotype
C4 could be further divided into C4a and C4b clusters.
Figure 2 Phylogenetic analysis based on the alignment of the 488 nucleotide VP1 gene of 15 Shanghai CA16 strains. The 25 reference
strains were obtained from the US National Center for Biotechnology Information’s Genbank.
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The Shanghai EV71 strains clustered in C4a, closely re-
lated to strains like Fuyang 22, DTID/ZJU-62 which
were detected in China in 2008 (Figure 1).
The nucleotide homologies within all the CA16 strains
ranged from 88.4% to 99.1%. Phylogenic analysis of the
partial VP1 coding sequences showed all the CA16
strains belonged to the B genotype. Six sequences that
were closely related to strains circulating in China (such
as HK08-7 and QH0269T) belonged to a B1a cluster,
and nine sequences belonged to a B1b cluster, which are
closely related to strains identified in Vietnam, Australia,
Malaysia and China (Figure 2).
Figure 3 Phylogenetic analysis based on the alignment of the 248 nucleotide VP1 gene of 23 Shanghai CA6 strains. The 28 reference
strains were obtained from the US National Center for Biotechnology Information’s Genbank.
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Of the 23 CA6 partial VP1 gene sequences used for
phylogenetic analysis, the nucleotide homologies ranged
from 89.8% to 99.0%. The CA6 strains appeared in two
branches, 15 of which were closely related to the 09s81
and 09s82 strains detected in Japan in 2009, and another
8 strains were closely related to strains circulating in
China and Taiwan (Figure 3).
The nucleotide homologies of CA10 strains ranged
from 95.8% to 99.5%. These strains were closely related
to the CA10 strains found in China in 2009 and distantly
related to the CA10 strain reported in China in 2004
and 2006 and to strains in France and India (Figure 4).
Both the CA12 and CA4 strains were most closely re-
lated to the other CA12 and CA4 strains found previ-
ously in Jiangsu and Yunnan provinces of China.
Clinical features of infected patients
All the patients ranged from 6 to 153 months (31.6 ±
19.2M), and 63.1% (183/290) were boys. Almost half the
patients had complications such as neurologic, respira-
tory or circulatory system symptoms.
Compared to patients without EV71 infection, patients
with EV71 infection were older (33.8 ± 20.3M vs 27.8 ±
16.3M, P < 0.05), had longer hospital stays (4.1 ± 2.4d vs
Figure 4 Phylogenetic analysis based on the alignment of the 355 nucleotide VP1 gene of 23 Shanghai CA10 strains. The 25 reference
strains were obtained from the US National Center for Biotechnology Information’s Genbank.
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3.2 ± 1.1d, P < 0.05), and higher complication rates (57.8%
vs 33.3%, P < 0.001).
When we divided patients into 5 groups infected with
different enterovirus genotypes, patients with EV71 in-
fection had significantly longer mean hospital stays and
a higher incidence of complications than those patients
in the CA6, CA10, and CA16 infection groups (P < 0.05),
but not than those in the CA12 infection group. Patients
infected with CA12 were the youngest of the groups and
had a higher risk of complications than that of the other
non-EV71 infection groups, but the differences were not
statistically significant (Table 1).
Discussion
In this study, we identified a variety of enterovirus geno-
types, including EV71, CA10, CA6, CA16, CA12, CA4,
CA14, Echo6, and EV-C, from stool samples of patients
hospitalized for HFMD in Shanghai, China. Our results
show a diversified pathogen compositions which are simi-
lar with reports from other areas of China, Korea and
Singapore [13-15].
The most common genotypes in our study all belonged
to species A, in which EV71 occupied the predominant
position with the highest detection rate of 63.8%. Since the
late 1990s, EV71-related HFMD outbreaks have often been
reported in the Asia-Pacific region, including Malaysia,
Taiwan, Perth, Japan and China [7,19-25]. Thus, EV71 has
been identified as the most prevalent genotype causing
HFMD in recent years.
EV71 is classified into three genotypes (A, B, and C)
on the basis of their phylogenetic relationship of the
VP1 structural sequences. At present, the B genotype
contains 6 subgenotypes (B0 through B5), whereas the C
genotype contains 5 subgenotypes (C1 through C5)
[26-32]. The frequency of these subgenotypes differs
over time and area. In Malaysia, the prevalent sub-
genotypes were C1, C2, B3, and B4 in 1997, but C1 and
C3 in 2000 and B5 and C1 in 2003 and 2005, respect-
ively [33]. The epidemic genotypes in Taiwan were C2 in
1998 but B4 from 2000 to 2003, C5 in 2006, and B5 in
2008 [34,35].
The predominant subgenotype of EV71 in shanghai
during 2010 and 2011 was subgenotype C4, cluster C4a,
which is most closely related to the Fuyang22 and
DTID/ZJU-62 strains isolated in China. During the past
10 years, the endemic circulation of subgenotype C4 has
changed. From 1998 to 2004, EV71 belonged to cluster
C4b, but after 2004, cluster C4a replaced C4b and
became the predominant virus circulating in China
[6,13,36,37]. Our results further confirmed the absolutely
dominant position of the EV71 C4a subgenotype in
China.
Another major pathogen, CA16, was thought to be as-
sociated with mild HFMD without severe neurological
complications. The rate of evolution of CA16 strains is
far below that of EV71 strains, but sequence information
is limited [12]. CA16 has been divided into genogroups
A and B, while genogroup B could be further divided
into subgenotype B1 and B2 [38]. In our study, B1 was
the only prevalent subgenotype, as it was in the CA16
strains in China, Taiwan, Malaysia, Thailand, Vietnam
and other areas isolated during 1999 to 2008 [31,39-42].
The higher detection rate of CA6 and CA10, when
compared to that of CA16, indicates the importance of
these two pathogens in HFMD. Occasional CA6- or
CA10-related HFMD outbreaks have been reported. For
example, in Singapore, both CA6 and CA10 had a detec-
tion rate of 35.3% in a HFMD outbreak in 2008 [14].
The prevalence of CA6 and CA10 was as high as 71%
and 28%, respectively, in Finland in 2008, and 28% and
39.9%, respectively, in France in 2010 [43,44]. A CA6-
related HFMD outbreak was also reported in Taiwan in
2010 [45]. However, phylogenetic trees analysis was
rarely conducted for these two viruses.
Table 1 Characteristics and symptoms of HFMD patients according to different enterovirus genotypes
Characteristics EV71 CA6 CA10 CA12 CA16 Total
(n = 185) (n = 24) (n = 26) (n = 7) (n = 20) (n = 290)
Age (M) 33.8 ± 20.3 26.4 ± 14.8 25.6 ± 12.2* 16.6 ± 7.8*/# 33.8 ± 8.5 31.6 ± 19.2
Male, n(%) 119 (64.3) 16 (66.7) 17 (65.4) 6 (85.7) 9 (45) 183 (63.1)
Hospital stay (d) 4.1 ± 2.4 2.9 ± 0.8* 2.9 ± 1.0* 3.4 ± 1.4 3.3 ± 1.4* 3.7 ± 1.5
Fever (>37°C), n(%) 175 (94.6) 20 (83.3)* 26 (100) 7 (100) 20 (100) 275 (94.8)
Vomiting, n(%) 72 (39.0) 6 (25) 0 (0)* 0 (0)* 5 (25) 98 (33.8)
Limb shaking, n(%) 41 (22.2) 1 (4.2)* 3 (11.5) 0 (0) 0 (0)* 47 (16.2)
Babinski’s sign, n(%) and/or Brudzinski’s sign, n(%) 5 (2.7) 0 (0) 0 (0) 0 (0) 0 (0) 7 (2.4)
Complication, n(%) 107 (57.8) 4 (16.7)* 7 (26.9)* 3 (42.9) 5 (25)* 142 (49.0)
*: Compared with EV71 infection group, P < 0.05.
#: CA12 infection group compared with CA16 infection group, P < 0.05.
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In this study, we compared the sequences from our
samples to those in Genbank and found that the Shang-
hai CA6 strain was closely related to strains isolated
from Japan, Taiwan, and China. The Shanghai CA6
strain belonged to two evolutionary clusters with a high
nucleotide homology, whereas all the CA10 strains were
most closely related to the strains found in the Shan-
dong and Yunnan provinces of China.
Although not prevalent, CA4 and CA12 were identi-
fied as pathogens attributing to HFMD in Shanghai.
CA4 caused a high infection rate in preschool children
in Taiwan from 2006 to 2008, whereas only one case of
CA4 infection were reported in Korea in 2009 [14,41].
Sporadic HFMD cases with CA12 infection were seen in
other areas of China between 2008 and 2009 [13,46,47].
Most enterovirus infections are self-limited and do not
require hospitalization, but EV71 infection in young
children frequently cause complications and can pro-
gress quickly [3,48,49]. However the clinical characteris-
tics of enterovirus genotypes, other than EV71 and
CA16, have not been well studied. We found that
HFMD cases infected with CA6, CA10 and CA16 caused
less complications compared to those infected with
EV71. But worth of note, the patients infected with
CA12 had the youngest age of onset and most likely
have the highest incidence of complications than any of
the other non-EV71 infection groups. Since there were
only 7 cases in this group, more study and data are
needed for accurately identifying the pathogenetic char-
acteristic of CA12 infections in China. In addition, we
did not observe the clinical symptoms, such as skin ul-
ceration and an obvious onychomadesis, that were asso-
ciated with CA6-caused HFMD in Finland, Taiwan and
Spain [45,50,51].
One limitation of this study is that different samples
were not taken in the patients i.e. throat swab, vesicle
and CSF which may influence the integrality of the data
and bring bias to the conclusion. Due to the retrospect-
ive nature of the study, stools were the only specimen
sent routinely to virology laboratory for enterovirus test-
ing and collection of more types of samples could not be
performed. However, it is widely recognized that HFMD
is a common disease of children mostly associated with
the human enterovirus species A. All the stools were
from hospitalized patients clinically diagnosed with
HFMD, and all the specimens were collected during the
acute phase of the illness. Thus we think that the entero-
virus identified in the stool specimen could represent
the pathogen causing HFMD and had a great relation-
ship with the clinical symptoms. In the future, to eluci-
date further the epidemiology of the pathogens for
HFMD, a prospective study will be developed and mul-
tiple clinical specimens from the same patient need to
be taken and evaluated.
Conclusions
In summary, this study provides useful epidemiological
data on the features of the pathogen compositions of
HFMD as well as clinical characteristics differing in en-
terovirus genotypes in Shanghai, China. It deserves our
attention that early identification of enterovirus geno-
types is important for diagnosis and treatment of HFMD
patients.
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